Fundingisrequestedforyears41-45ofalongstandingandsuccessfultrainingprogramincancer researchatTheWistarInstitute.Supportisrequestedfor4predoctoraland8postdoctoraltrainees. PredoctoraltraineesarePh.D.orM.D./Ph.D.candidateswhoconductcancer-relatedthesisresearchat theWistarInstituteinpartialfulfillmentofthePh.D.requirementsoftheUniversityofPennsylvania. Postdoctoraltrainingisdesignedtoprepareindividualsforindependentresearchcareersincancer- relatedareasinbasicresearchandclinicalsettings.Theprogramisdevotedtolaboratoryresearch trainingthatiscomplementedbyabiweeklyResearchinProgressSeries,aweeklycancer-focused WistarInstituteDistinguishedLectureSeries,abiweeklyCancerBiologyJournalClub,abiyearlyCancer BiologyRetreat,aCancerBiologyLectureCourse,ayearlyworkshopinGrantProposalPlanningand PreparationandyearlytraininginTheResponsibleConductofResearch.Traineesalsoactively participateinotherrelevantlecturesseriesandnationalandinternationalconferences. Theproposedtrainershead20independentlaboratoriesfromthefourprogramsattheWistarInstitute;? GeneExpressionandRegulation,MolecularandCellularOncogenesis,TranslationalTumorImmunology andTumorMicroenvironmentandMetastasis.Trainersparticipateinalltrainingprogramactivities includingtherecruitmentintotheprogramofUnderrepresentedscientists.Thetrainersintheprogram shareacommoninterestincancerresearchandtogethercoverbothbasicandtranslationalaspects.A uniquefeatureoftheprogramisthatitisunusuallyinteractiveandcollaborative,resultinginmany programprojectsandcollaborativepublicationsinvolvingtrainersandtraineesbothwithinandbetween thefourinstituteprograms. Allparticipatingtrainerscontinuallysucceedinattractingoutstandingpredoctoralandpostdoctoral fellows,andeachhassuccessfullycompetedforpredominantlyfederalgrantsupportincancerresearch, with65%oftheparticipatingtrainerssupportedbytheNCIandtherestofthetrainerssupportedbyother cancer-relatedfunding.Altogether,thisprogramofferstrainingin?cuttingedge?researchthatwill prepareourtraineesforproductiveindependentcareersinbasicandtranslationalcancerresearch.
Fundingisrequestedtocontinuethetrainingofindividualsforcareersincancerresearch.Thistraining programofferstrainingin?cuttingedge?basiccancerresearchthatwillpreparetheparticipatingtrainees foraproductivecareerinsciencethatwilladvanceourunderstandingofthemalignantprocess.
| Patel, Sima; Fu, Shuyu; Mastio, Jerome et al. (2018) Unique pattern of neutrophil migration and function during tumor progression. Nat Immunol 19:1236-1247 |
| Gnanapradeepan, Keerthana; Basu, Subhasree; Barnoud, Thibaut et al. (2018) The p53 Tumor Suppressor in the Control of Metabolism and Ferroptosis. Front Endocrinol (Lausanne) 9:124 |
| EchevarrÃa-Vargas, Ileabett M; Reyes-Uribe, Patricia I; Guterres, Adam N et al. (2018) Co-targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor-resistant melanoma. EMBO Mol Med 10: |
| Basu, Subhasree; Gnanapradeepan, Keerthana; Barnoud, Thibaut et al. (2018) Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1?. Genes Dev 32:230-243 |
| Perales-Puchalt, Alfredo; Perez-Sanz, Jairo; Payne, Kyle K et al. (2018) Frontline Science: Microbiota reconstitution restores intestinal integrity after cisplatin therapy. J Leukoc Biol 103:799-805 |
| Reyes-Uribe, Patricia; Adrianzen-Ruesta, Maria Paz; Deng, Zhong et al. (2018) Exploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanoma. Oncogene 37:4058-4072 |
| Fukumoto, Takeshi; Park, Pyoung Hwa; Wu, Shuai et al. (2018) Repurposing Pan-HDAC Inhibitors for ARID1A-Mutated Ovarian Cancer. Cell Rep 22:3393-3400 |
| Kaur, Amanpreet; Ecker, Brett L; Douglass, Stephen M et al. (2018) Remodeling of the Collagen Matrix in Aging Skin Promotes Melanoma Metastasis and Affects Immune Cell Motility. Cancer Discov : |
| Barnoud, Thibaut; Schmidt, M Lee; Donninger, Howard et al. (2017) The role of the NORE1A tumor suppressor in Oncogene-Induced Senescence. Cancer Lett 400:30-36 |
| Veglia, Filippo; Tyurin, Vladimir A; Mohammadyani, Dariush et al. (2017) Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancer. Nat Commun 8:2122 |
Showing the most recent 10 out of 228 publications
